| Autor: |
Hoyes KP; Cancer Research Campaign Department of Experimental Radiation Oncology, Paterson Institute for Cancer Research, Manchester, UK., Johnson C, Johnston RE, Lendon RG, Hendry JH, Sharma HL, Morris ID |
| Jazyk: |
angličtina |
| Zdroj: |
Reproductive toxicology (Elmsford, N.Y.) [Reprod Toxicol] 1995 May-Jun; Vol. 9 (3), pp. 297-305. |
| DOI: |
10.1016/0890-6238(95)00012-y |
| Abstrakt: |
Adult (70 d) and neonatal (7 d) male rats were dosed (i.p.) with 37 MBq/kg (1 mCi/kg; approximately 1 microgram elemental indium/kg) 114mIn, a transferrin-binding radionuclide. In adults, approximately 0.25% of the injected activity localised within the testis by 48 h postinjection and remained constant for up to 63 d. In neonates, 0.06% of the activity was in the testis by 48 h, and this declined such that by 63 d only 0.03% remained. At 63 d, treated rats had reduced sperm head counts and abnormal testicular histology that was more marked in animals dosed as adults than as neonates. In vitro, uptake of 114mIn into seminiferous tubules isolated from 7-, 20-, or 70-d-old rats was compared with that of 125I. Both radionuclides were readily accumulated by the tubules. Whilst 114In uptake into 20- and 70-d tubules was inhibited by excess transferrin, uptake into 7-d tubules was unchanged. 125I uptake was not affected by excess transferrin. These data support the contention that some radionuclides may cross the blood-testis barrier by utilisation of the physiologic iron-transferrin pathway, which may lead to greater testicular damage in adult compared to neonatal animals. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
Full Text from ScienceDirect